The Fort Worth Press - Wellgistics Health Converts $8.1M Debt to Equity

USD -
AED 3.672501
AFN 64.999904
ALL 81.827235
AMD 365.160186
ANG 1.789785
AOA 918.000035
ARS 1544.520502
AUD 1.464697
AWG 1.8
AZN 1.70654
BAM 1.762379
BBD 2.036128
BDT 126.028385
BGN 1.747831
BHD 0.381383
BIF 3024.210446
BMD 1
BND 1.292395
BOB 11.989636
BRL 5.588899
BSD 1.010945
BTN 95.007435
BWP 13.869176
BYN 3.0269
BYR 19600
BZD 2.033164
CAD 1.424925
CDF 2314.999957
CHF 0.832015
CLF 0.025031
CLP 985.150033
CNY 6.67035
CNH 6.667815
COP 3290.1
CRC 457.263359
CUC 1
CUP 24.260419
CVE 99.36917
CZK 21.971349
DJF 180.019916
DKK 6.740195
DOP 61.316908
DZD 136.811916
EGP 53.424398
ERN 15
ETB 164.541452
EUR 0.90164
FJD 2.269699
FKP 0.753031
GBP 0.753675
GEL 2.598862
GGP 0.753031
GHS 11.838234
GIP 0.753031
GMD 74.000009
GNF 8956.017465
GTQ 7.724958
GYD 211.837332
HKD 7.84455
HNL 27.174457
HRK 6.76901
HTG 132.510848
HUF 328.569002
IDR 18250.85
ILS 3.18214
IMP 0.753031
INR 94.02255
IQD 1532.417211
IRR 1906074.999995
ISK 123.160083
JEP 0.753031
JMD 160.446988
JOD 0.709014
JPY 159.634007
KES 129.989924
KGS 87.448898
KHR 4122.94022
KMF 442.000327
KPW 899.999961
KRW 1332.289534
KWD 0.31123
KYD 0.842352
KZT 451.299842
LAK 22755.230323
LBP 90528.995629
LKR 335.972315
LRD 171.855991
LSL 16.573648
LTL 2.95274
LVL 0.60489
LYD 6.480393
MAD 9.86162
MDL 18.166334
MGA 4574.394744
MKD 55.475183
MMK 2099.724407
MNT 3604.903758
MOP 8.167515
MRU 40.781511
MUR 47.359553
MVR 15.401286
MWK 1752.977277
MXN 18.65444
MYR 4.079603
MZN 63.903308
NAD 16.571931
NGN 1347.119939
NIO 37.201087
NOK 9.550335
NPR 152.012581
NZD 1.797515
OMR 0.384496
PAB 1.010972
PEN 3.44501
PGK 4.540191
PHP 63.695008
PKR 277.574021
PLN 3.97037
PYG 6240.678409
QAR 3.685126
RON 4.820402
RSD 106.032019
RUB 82.92646
RWF 1495.696841
SAR 3.772213
SBD 8.090747
SCR 13.850898
SDG 601.499938
SEK 9.96171
SGD 1.285205
SHP 0.749316
SLE 22.900483
SLL 20969.504398
SOS 577.749741
SRD 37.645982
STD 20697.981008
STN 22.079133
SVC 8.845235
SYP 13001.999685
SZL 16.578126
THB 33.789482
TJS 9.290497
TMT 3.5
TND 3.012932
TOP 2.40776
TRY 50.257596
TTD 6.855598
TWD 32.963045
TZS 2658.292955
UAH 45.980237
UGX 4124.816943
UYU 40.90479
UZS 12104.528047
VES 900.490499
VND 25679.5
VUV 119.943861
WST 2.787799
XAF 591.437181
XAG 0.019619
XAU 0.000253486067
XCD 2.70255
XCG 1.821762
XDR 0.707052
XOF 591.437181
XPF 107.465645
YER 236.498233
ZAR 16.66175
ZMK 9001.197482
ZMW 20.597486
ZWL 321.999592
SSP 5786.523514
MXV 2.095462
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Wellgistics Health Converts $8.1M Debt to Equity
Wellgistics Health Converts $8.1M Debt to Equity

Wellgistics Health Converts $8.1M Debt to Equity

TAMPA, FLORIDA / ACCESS Newswire / July 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that its Board of Directors has approved an $8.1 million debt-to-equity conversion.

Text size:

Led by CEO Brian Norton and former minority partners of Wellgistics, LLC, which was acquired by Wellgistics Health in 2024, the transaction strengthens the Company's balance sheet by materially reducing the Company's short-term debt.

The transaction is also expected to:

  • Accelerate the Company's cash flow by unlocking more favorable terms and capital access;

  • Improve Wellgistics Health's ability to acquire high-demand pharmaceutical products at competitive prices;

  • Expand the Company's national footprint by growing its network of independent pharmacies; and

  • Strengthen the Company's proprietary technology platform, including AI-powered hub services and digital prescription routing

"This conversion will make a significant contribution in enabling us to accelerate our business plan and accomplish the goals we believe will help transform the prescription drug marketplace and drive long-term value for our shareholders," said Wellgistics Health CFO Mark DiSiena.

"We look forward to sharing additional positive developments in the near future."

About Wellgistics Health

Wellgistics Health (NASDAQ: WGRX) delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies and 200+ U.S. manufacturers, offering wholesale distribution, digital script routing, and AI-driven hub services like eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health delivers seamless, compliant, end-to-end solutions designed to restore access, transparency, and trust in U.S. healthcare.

Forward-Looking Statements

This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at www.sec.gov.

For more information, please contact:

Media Contact: [email protected]
Investor Relations: [email protected]

Investor Relations Contact:

Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: [email protected]

SOURCE: Wellgistics Health, Inc.



View the original press release on ACCESS Newswire

T.Harrison--TFWP